Paxlovid - COVID-19 Antiviral Treatment Check Eligibility

paxlovid  INDICATION close PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 in adults who are at high risk for Avoid concomitant use with PAXLOVID The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT

nirmatrelvirritonavir 150100 mg PO BID x 5 days Other may be necessary while taking Paxlovid AND Paxlovid is an oral coronavirus medicine used in outpatient treatment for people aged 18 or over and at risk of developing the severe form of COVID-19 due to

Paxlovid is given to people who are at most risk of becoming very unwell from a COVID-19 virus infection It may help you become less sick and Paxlovid is 2 medicines that you take together They reduce the amount of virus in your body You take Paxlovid